Konstantinos Lykopoulos
About Konstantinos Lykopoulos
Konstantinos Lykopoulos serves as the Executive Director of Global Market Access Strategy and HEOR at Kite Pharma, focusing on personalized medicine in oncology and haematology. He has a strong background in health policy and economics, with previous roles at GSK and ViiV Healthcare.
Work at Kite Pharma
Konstantinos Lykopoulos serves as the Executive Director of Global Market Access Strategy and Health Economics Outcomes Research (HEOR) at Kite Pharma. He has held this position since 2018, contributing to the company's focus on personalized medicine and specialist care in oncology and hematology. His role involves developing strategies that facilitate market access for Kite's innovative therapies, ensuring that patients can benefit from advanced treatment options.
Education and Expertise
Konstantinos Lykopoulos studied at The London School of Economics and Political Science (LSE), where he earned a Master of Science in International Health Policy and Health Economics from 2003 to 2004. He also holds a Bachelor of Science in Pathology and Medicine from Imperial College London, completed over a seven-year period from 1995 to 2002. His educational background provides a strong foundation for his expertise in health economics and market access strategies.
Background
Before joining Kite Pharma, Konstantinos Lykopoulos accumulated significant experience in the pharmaceutical industry. He worked at GlaxoSmithKline (GSK) as the Director of Global Market Access and Healthcare Solutions for the Respiratory Franchise from 2008 to 2015. His career also includes roles as a Senior Consultant at Total Healthcare Solutions from 2004 to 2008 and as a Senior Director of Health Outcomes at ViiV Healthcare from 2015 to 2018.
Achievements
Throughout his career, Konstantinos Lykopoulos has developed extensive experience in scientific and commercial market access disciplines, with a strong focus on payer customer engagement. His work has contributed to the successful implementation of market access strategies that enhance patient access to healthcare solutions in various therapeutic areas, particularly in oncology and respiratory health.